← Back to Screener
iRadimed Corporation (IRMD)
Price$93.07
Value ScoreD
Growth ScoreB
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-8.09%
Price vs S&P 500 (4W)7.87%
VGM Score55.61
Market Capitalization$1.19B
P/E Ratio (Annual)52.92x
Indicated Dividend Yield (Annual)0.79%
All Metrics
P/CF (Annual)47.69x
Book Value / Share (Quarterly)$7.71
P/TBV (Annual)13.56x
Indicated Dividend (Annual)$0.80
Revenue Growth (3Y)16.29%
Cash Flow / Share (Quarterly)$1.88
Payout Ratio (TTM)65.37%
Price vs S&P 500 (YTD)-12.49%
Gross Margin (TTM)76.84%
Net Profit Margin (TTM)27.36%
EPS (TTM)$1.84
10-Day Avg Trading Volume0.14M
EPS Excl Extra (TTM)$1.84
Revenue Growth (5Y)21.45%
EPS (Annual)$1.75
Dividend / Share (Annual)$1.18
ROI (Annual)23.76%
Gross Margin (Annual)76.75%
Net Profit Margin (5Y Avg)25.14%
Cash / Share (Quarterly)$4.41
P/E Basic Excl Extra (TTM)50.39x
Revenue Growth QoQ (YoY)12.65%
EPS Growth (5Y)73.86%
P/E Normalized (Annual)52.92x
ROA (Last FY)20.67%
Revenue Growth TTM (YoY)14.81%
EBITD / Share (TTM)$2.28
ROE (5Y Avg)20.07%
Operating Margin (TTM)32.40%
Cash Flow / Share (Annual)$1.29
P/B Ratio12.08x
P/B Ratio (Quarterly)12.49x
Net Income / Employee (Annual)$135,400
EV / Revenue (TTM)13.14x
Net Interest Coverage (TTM)1096.00x
ROA (TTM)21.25%
EPS Growth QoQ (YoY)23.69%
EV / EBITDA (TTM)38.58x
EPS Incl Extra (Annual)$1.75
Current Ratio (Annual)7.98x
Quick Ratio (Quarterly)5.76x
3-Month Avg Trading Volume0.10M
52-Week Price Return54.19%
EV / Free Cash Flow (Annual)68.58x
P/E Incl Extra (TTM)50.39x
Revenue / Employee (TTM)$519,800
Tangible BV / Share (Quarterly)$7.45
P/S Ratio (Annual)14.19x
Asset Turnover (Annual)0.77x
52-Week High$107.90
Operating Margin (5Y Avg)28.91%
EPS Excl Extra (Annual)$1.75
CapEx CAGR (5Y)67.43%
Tangible BV CAGR (5Y)8.59%
26-Week Price Return-0.16%
Quick Ratio (Annual)6.37x
13-Week Price Return-7.02%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)7.13x
Enterprise Value$1.13B
Revenue / Share Growth (5Y)20.66%
Asset Turnover (TTM)0.78x
Book Value / Share Growth (5Y)8.22%
Revenue / Employee (Annual)$504,900
Inventory Turnover (Annual)1.77x
Pretax Margin (Annual)33.84%
Cash / Share (Annual)$4.00
3-Month Return Std Dev31.08%
Gross Margin (5Y Avg)76.86%
Net Income / Employee (TTM)$142,200
EBITDA CAGR (5Y)116.07%
EBITDA Interim CAGR (5Y)29.52%
ROE (Last FY)23.76%
EPS Basic Excl Extra (Annual)$1.75
P/FCF (TTM)49.63x
Receivables Turnover (TTM)6.61x
EV / Free Cash Flow (TTM)47.28x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$1.84
Receivables Turnover (Annual)6.92x
ROI (TTM)24.48%
P/S Ratio (TTM)13.79x
Pretax Margin (5Y Avg)30.81%
Revenue / Share (Annual)$6.52
Tangible BV / Share (Annual)$7.14
Forward P/E41.41x
Free OCF CAGR (5Y)26.12%
Price vs S&P 500 (52W)29.83%
P/E Ratio (TTM)50.39x
EPS Growth TTM (YoY)18.75%
Year-to-Date Return-4.33%
5-Day Price Return1.11%
EPS Normalized (Annual)$1.75
ROA (5Y Avg)17.03%
Net Profit Margin (Annual)26.82%
Month-to-Date Return2.66%
Cash Flow / Share (TTM)$1.34
EBITD / Share (Annual)$2.12
EPS Growth (3Y)19.89%
Operating Margin (Annual)31.20%
P/CF (TTM)41.10x
ROI (5Y Avg)20.07%
P/E Excl Extra (TTM)50.39x
EPS Basic Excl Extra (TTM)$1.84
P/TBV (Quarterly)12.92x
Payout Ratio (Annual)66.90%
P/B Ratio (Annual)13.08x
Dividend / Share (TTM)$1.21
Inventory Turnover (TTM)1.78x
Pretax Margin (TTM)34.98%
Book Value / Share (Annual)$7.40
Price vs S&P 500 (13W)-15.28%
Net Margin Growth (5Y)44.08%
Dividend Yield (TTM)1.30%
Beta0.91x
P/FCF (Annual)71.99x
Revenue / Share (TTM)$6.70
ROE (TTM)24.48%
52-Week Low$55.11
vGradeD
gGradeB
mGradeB
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.49est. 0.45
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.13
4.13
4.13
4.11
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IRMDiRadimed Corporation | D | B | B | $93.07 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
iRadimed manufactures MRI-compatible medical devices, including non-magnetic IV infusion pump systems and patient vital signs monitors for use during MRI procedures. The company sells to hospitals and acute care facilities in the United States and internationally, with the majority of revenue derived from the U.S. market.